ATE298002T1 - Vererbliches hemochromatosis-gen - Google Patents

Vererbliches hemochromatosis-gen

Info

Publication number
ATE298002T1
ATE298002T1 AT97918642T AT97918642T ATE298002T1 AT E298002 T1 ATE298002 T1 AT E298002T1 AT 97918642 T AT97918642 T AT 97918642T AT 97918642 T AT97918642 T AT 97918642T AT E298002 T1 ATE298002 T1 AT E298002T1
Authority
AT
Austria
Prior art keywords
gene
relates
therapeutics
heritable
diagnosis
Prior art date
Application number
AT97918642T
Other languages
English (en)
Inventor
Winston J Thomas
Dennis T Drayna
John N Feder
Andreas Gnirke
David Ruddy
Zenta Tsuchihashi
Roger K Wolff
Original Assignee
Bio Rad Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/632,673 external-priority patent/US5712098A/en
Application filed by Bio Rad Laboratories filed Critical Bio Rad Laboratories
Application granted granted Critical
Publication of ATE298002T1 publication Critical patent/ATE298002T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
AT97918642T 1996-04-04 1997-04-04 Vererbliches hemochromatosis-gen ATE298002T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US63091296A 1996-04-04 1996-04-04
US08/632,673 US5712098A (en) 1996-04-04 1996-04-16 Hereditary hemochromatosis diagnostic markers and diagnostic methods
US08/652,265 US6025130A (en) 1996-04-04 1996-05-23 Hereditary hemochromatosis gene
PCT/US1997/006254 WO1997038137A1 (en) 1996-04-04 1997-04-04 Hereditary hemochromatosis gene

Publications (1)

Publication Number Publication Date
ATE298002T1 true ATE298002T1 (de) 2005-07-15

Family

ID=27417504

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97918642T ATE298002T1 (de) 1996-04-04 1997-04-04 Vererbliches hemochromatosis-gen

Country Status (7)

Country Link
US (2) US6025130A (de)
EP (2) EP1591537B1 (de)
AT (1) ATE298002T1 (de)
AU (1) AU733459B2 (de)
CA (1) CA2253240C (de)
DE (2) DE954602T1 (de)
WO (1) WO1997038137A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674681A (en) * 1994-12-06 1997-10-07 Rothenberg; Barry E. Methods to identify hemochromatosis
US6025130A (en) * 1996-04-04 2000-02-15 Mercator Genetics, Inc. Hereditary hemochromatosis gene
US7026116B1 (en) * 1996-04-04 2006-04-11 Bio-Rad Laboratories, Inc. Polymorphisms in the region of the human hemochromatosis gene
US6140305A (en) * 1996-04-04 2000-10-31 Bio-Rad Laboratories, Inc. Hereditary hemochromatosis gene products
US6849399B1 (en) 1996-05-23 2005-02-01 Bio-Rad Laboratories, Inc. Methods and compositions for diagnosis and treatment of iron misregulation diseases
DE69738157T2 (de) * 1996-10-01 2008-05-08 Bio-Rad Laboratories, Inc., Hercules Polymorphismus und neue gene in der region des menschlichen hemochromatosisgens
ATE462717T1 (de) * 1997-06-13 2010-04-15 Bio Rad Laboratories Verfahren und zusammensetzungen für die diagnose und die behandlung von krankheiten, die mit eisenüberschuss oder eisenmangel assoziiert sind
US5994078A (en) * 1997-07-31 1999-11-30 Maine Medical Center Stable encapsulated reference nucleic acid and method of making
US20030165888A1 (en) * 2001-07-18 2003-09-04 Brown Bob D. Oligonucleotide probes and primers comprising universal bases for diagnostic purposes
US6518017B1 (en) * 1997-10-02 2003-02-11 Oasis Biosciences Incorporated Combinatorial antisense library
FR2785295A1 (fr) * 1998-10-29 2000-05-05 Assist Publ Hopitaux De Paris Procede d'evaluation du risque d'apparition d'une surcharge en fer et ses applications
US6284732B1 (en) 1998-12-18 2001-09-04 Bio-Rad Laboratories, Inc. Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
CZ303703B6 (cs) 1998-12-23 2013-03-20 Pfizer Inc. Monoklonální protilátka nebo její antigen-vázající fragment, farmaceutická kompozice obsahující tuto protilátku nebo fragment, bunecná linie produkující tuto protilátku nebo fragment, zpusob prípravy této protilátky, izolovaná nukleová kyselina kóduj
US7109003B2 (en) 1998-12-23 2006-09-19 Abgenix, Inc. Methods for expressing and recovering human monoclonal antibodies to CTLA-4
EE05627B1 (et) 1998-12-23 2013-02-15 Pfizer Inc. CTLA-4 vastased inimese monoklonaalsed antikehad
US6355425B1 (en) * 1999-03-26 2002-03-12 Billups-Rothenberg, Inc. Mutations associated with iron disorders
US20020025519A1 (en) * 1999-06-17 2002-02-28 David J. Wright Methods and oligonucleotides for detecting nucleic acid sequence variations
US20030165913A1 (en) * 1999-06-17 2003-09-04 Sha-Sha Wang Methods for detecting nucleic acid sequence variations
EP3214175A1 (de) 1999-08-24 2017-09-06 E. R. Squibb & Sons, L.L.C. Humane ctla-4-antikörper und verwendungen davon
DE10032529A1 (de) * 2000-06-30 2002-02-07 Epigenomics Ag Diagnose von bedeutenden genetischen Parametern innerhalb des Major Histocompatibility Complex (MHC)
AU2001251449B2 (en) 2000-04-06 2005-04-07 Conlinco, Inc. Conjugated linoleic acid compositions
AT412282B (de) * 2000-05-02 2004-12-27 Viennalab Labordiagnostika Gmb Verfahren und sonde zur diagnose von hämochromatose
US7262030B2 (en) * 2001-05-09 2007-08-28 Virginia Commonwealth University Multiple sequencible and ligatible structures for genomic analysis
US6762293B2 (en) * 2001-06-29 2004-07-13 Erasmus University Rotterdam Diagnostics and therapeutics for autosomal dominant hemochromatosis
US7135174B2 (en) 2002-01-07 2006-11-14 Amgen Fremont, Inc. Antibodies directed to PDGFD and uses thereof
AU2003230653A1 (en) * 2002-03-15 2003-09-29 Wisconsin Alumni Research Foundation Method of identifying genes controlling diferentiation
AU2003234736B2 (en) 2002-04-12 2008-09-25 E. R. Squibb & Sons, L.L.C. Methods of treatment using CTLA-4 antibodies
EP1400597A1 (de) * 2002-09-20 2004-03-24 Becton, Dickinson and Company Oligonukleotide zur Amplifizierung und zum Nachweis vom hemochromatosis Gen
US8067544B2 (en) 2003-03-19 2011-11-29 Curagen Corporation Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof
WO2004098386A2 (en) 2003-05-01 2004-11-18 Gen-Probe Incorporated Oligonucleotides comprising a molecular switch
AU2006315580A1 (en) 2005-11-10 2007-05-24 Curagen Corporation Method of treating ovarian and renal cancer using antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen
NZ568016A (en) 2005-12-07 2011-12-22 Medarex Inc CTLA-4 antibody dosage escalation regimens
US8071323B2 (en) 2006-04-07 2011-12-06 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Human monoclonal antibodies that bind human insulin like growth factors and their use
DK2185719T3 (en) 2007-08-02 2014-02-17 Novimmune Sa ANTI-RANTES ANTIBODIES AND PROCEDURES FOR USE THEREOF
MX2011011729A (es) 2009-05-05 2012-04-10 Novimmune Sa Anticuerpo anti il-17f y metodos de uso de los mismos.
EP2633317A1 (de) 2010-10-25 2013-09-04 Genentech, Inc. Behandlung von magen-darm-entzündung und psoriasis a
WO2012099871A1 (en) 2011-01-17 2012-07-26 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Modulation of lrch4 activity and therapeutic application thereof
WO2012142164A1 (en) 2011-04-12 2012-10-18 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Human monoclonal antibodies that bind insulin-like growth factor (igf) i and ii
ES2743203T3 (es) 2012-02-06 2020-02-18 Inhibrx Inc Anticuerpos CD47 y métodos de uso de los mismos
AU2013278075B2 (en) 2012-06-22 2018-05-17 Cytomx Therapeutics, Inc. Anti-jagged 1/Jagged 2 cross-reactive antibodies, activatable anti-Jagged antibodies and methods of use thereof
EP2953643B1 (de) 2013-02-06 2023-02-22 Inhibrx, Inc. Nicht-plättchen-depletierende und nicht-erythrozyten-depletierende cd47-antikörper und verfahren zur verwendung davon
EP3033356B1 (de) 2013-08-14 2020-01-15 Sachdev Sidhu Antikörper gegen frizzled proteine und verwendung davon

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025130A (en) * 1996-04-04 2000-02-15 Mercator Genetics, Inc. Hereditary hemochromatosis gene

Also Published As

Publication number Publication date
DE69733572T2 (de) 2006-05-04
CA2253240A1 (en) 1997-10-16
EP1591537B1 (de) 2016-02-03
US6025130A (en) 2000-02-15
US6228594B1 (en) 2001-05-08
EP0954602A1 (de) 1999-11-10
EP0954602B1 (de) 2005-06-15
AU733459B2 (en) 2001-05-17
WO1997038137A1 (en) 1997-10-16
DE69733572D1 (de) 2005-07-21
AU2670197A (en) 1997-10-29
DE954602T1 (de) 2002-08-22
EP1591537A3 (de) 2007-05-16
EP0954602A4 (de) 2003-04-02
EP1591537A2 (de) 2005-11-02
CA2253240C (en) 2011-08-09

Similar Documents

Publication Publication Date Title
ATE298002T1 (de) Vererbliches hemochromatosis-gen
Takahara et al. Type I procollagen COOH-terminal proteinase enhancer protein: identification, primary structure, and chromosomal localization of the cognate human gene (PCOLCE)
DE69636866D1 (en) Reverse "two-hybrid"-systeme
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
WO2002044426A3 (en) Nod2 nucleic acids and proteins
EP1616942A3 (de) Patched Gene und ihre Verwendung
NZ270659A (en) Mammalian protein which binds to a gst-fkbp-rapamycin complex, dna therefor and diagnostic compositions
CA2158750A1 (en) Monoclonal antibodies to casein kinase i polypeptides
WO1999053061A3 (en) Tumor associated nucleic acids and uses therefor
WO1997003192A3 (en) Chromosome 1 gene and gene products related to alzheimer's disease
WO2001068824A3 (en) Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
WO1995006735A3 (en) Nucleotide sequences for novel protein tyrosine phosphatases
WO2002040668A3 (de) Proteine und den proteinen zugrundeliegende dna-sequenzen mit funktion bei entzündungsereignissen
Balraj et al. An unusual mutation in RECQ4 gene leading to Rothmund–Thomson syndrome
ATE427959T1 (de) Gereinigtes sr-p70 protein
WO2002103015A3 (en) Abca10 transporter
WO2000024768A3 (en) Genes integrating signal transduction pathways
CA2273855A1 (en) Novel feline fc epsilon receptor alpha chain nucleic acid molecules, proteins and uses thereof
Yoshida et al. Cloning and characterization of the mouse tob gene
WO1995017522A3 (en) Identification of simple tandem repeats
WO1998024887A3 (en) Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof
WO1999022005A3 (en) Heparan sulfate d-glucosaminyl 3-o-sulfotransferases, an uses therefor
WO1999063094A3 (en) Nucleotide and protein sequences of gpr1 and methods based thereon
WO1999054436A3 (en) Nucleic acids and proteins of c. elegans insulin-like genes and uses thereof
Colin Gerbich blood groups and minor glycophorins of human erythrocytes

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0954602

Country of ref document: EP